Morgan Stanley says this under-the-radar biotech stock can rally more than 80%
Analyst Maxwell Skor upgraded the biotech stock to overweight from equal weight and raised his price target by $24 to $34.
Source: cnbc.com
Analyst Maxwell Skor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Analyst Maxwell Skor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Analyst Maxwell Skor Today - Breaking & Trending Today